questionText: To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure patients with vitiligo have access to effective treatments in the context of NICE's decision not to recommend Ruxolitinib for NHS use.
answerText: The Government wants National Health Service patients to be able to benefit from access to clinically and cost-effective new treatments, and the National Institute for Health and Care Excellence (NICE) makes recommendations for the NHS on whether new medi...
heading: Vitiligo: Medical Treatments